Another study from 2021 found that CDKN2A expression may have influenced how tumour-associated macrophages are regulated and that it can be used as a prognostic biomarker to assess the prognosis and immune infiltration in HCC [156]. This evidence concerns the gene CDKN2A and hepatocellular carcinoma.